.STUDY FEATURE.06 August 2024.
A huge randomized regulated test along with cisgender females highlights the obstacles of obedience to a daily oral preexposure treatment regiment and also displays that twice-yearly injection of lenacapavir can easily sustain effective HIV protection levels over 6 months.